MedKoo Cat#: 406726 | Name: PF-CBP1 free base
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PF-CBP1, also known as PF-06670910, is potent and highly-selective inhibitor of the bromodomain of CREB binding protein (CBP BRD) that down regulates targets of CBP in macrophages primary neurons.

Chemical Structure

PF-CBP1 free base
PF-CBP1 free base
CAS#1962928-21-7 (free base)

Theoretical Analysis

MedKoo Cat#: 406726

Name: PF-CBP1 free base

CAS#: 1962928-21-7 (free base)

Chemical Formula: C29H36N4O3

Exact Mass: 488.2787

Molecular Weight: 488.63

Elemental Analysis: C, 71.28; H, 7.43; N, 11.47; O, 9.82

Price and Availability

Size Price Availability Quantity
25mg USD 450.00 2 Weeks
100mg USD 750.00 2 Weeks
1g USD 3,850.00 2 Weeks
2g USD 5,850.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
PF-CBP1; PF-CBP-1; PF-CBP 1; PF-06670910; PF 06670910; PF06670910.
IUPAC/Chemical Name
4-(2-(5-(3,5-Dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine
InChi Key
CGWBJJZOKGZCSJ-UHFFFAOYSA-N
InChi Code
InChI=1S/C29H36N4O3/c1-4-17-35-25-9-5-23(6-10-25)7-12-28-30-26-20-24(29-21(2)31-36-22(29)3)8-11-27(26)33(28)14-13-32-15-18-34-19-16-32/h5-6,8-11,20H,4,7,12-19H2,1-3H3
SMILES Code
CCCOC1=CC=C(CCC2=NC3=CC(C4=C(C)ON=C4C)=CC=C3N2CCN5CCOCC5)C=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
PF-CBP1 is a highly selective inhibitor of the CREB binding protein bromodomain.
In vitro activity:
TBD
In vivo activity:
TBD
Solvent mg/mL mM comments
Solubility
DMF 30.0 61.40
DMF:PBS (pH 7.2) (1:1) 0.5 1.02
DMSO 20.0 40.93
Ethanol 20.0 40.93
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 488.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Chekler EL, Pellegrino JA, Lanz TA, Denny RA, Flick AC, Coe J, Langille J, Basak A, Liu S, Stock IA, Sahasrabudhe P, Bonin PD, Lee K, Pletcher MT, Jones LH. Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities. Chem Biol. 2015 Dec 17;22(12):1588-96. doi: 10.1016/j.chembiol.2015.10.013. Epub 2015 Dec 3. PubMed PMID: 26670081. Edmonds, A. (2022). The development of DUAL BRD4 and CBP/p300 degraders from ISOX-DUAL (Doctoral dissertation, University of Sussex). Muthengi, A. M. (2019). Multicomponent Reactions and Post Condensation Modifications for the Synthesis of Molecules With Biological Interests. University of Massachusetts Boston.